In this study, we are investigating the use of an experimental oral treatment for moderate to severe plaque psoriasis.
OVERVIEW
Participants will receive study medication for 28 days. There will be seven visits over approximately 10 weeks. This is an experimental treatment and is not yet approved in Australia.
ELIGIBILITY
PRINCIPAL INVESTIGATOR
CONTACT US
Please contact Holdsworth House Research to register your interest:
Phone: 02 8038 1044
Email: studies@holdsworthhouse.com.au
Or enter your details below to request more information.